Goldman Sachs and Morgan Stanley has collectively purchased 626,212 equity shares representing 1.05% stake in Strides Arcolab in past two trading sessions, the BSE bulk deal data shows.
On June 11, Goldman Sachs Investments Mauritius has bought 300,000 shares at Rs 626.28 per share, while on June 10, Morgan Stanley Asia (Singapore) PTE purchased 326,212 shares at Rs 623.62 per share, according to information available on the stock exchange.
The stock opened at Rs 626 and hit a 52-week high of Rs 648 on the BSE. A combined 440,314 shares changed hands on the counter till 1025 hours on the BSE and NSE.
Meanwhile, so far in current month, the stock has rallied 26% against 5.5% rise in benchmark S&P BSE Sensex and 4.2% rise in S&P BSE Healthcare index.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
